Steven Cohen’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Steven Cohen’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-80,700	Closed	-$993K	–	1578
2019 Q2	$993K	Buy	+80,700	New	+$931K	0.01%	773
2019 Q1	–	Sell	-1,194,600	Closed	-$13.5M	–	1308
2018 Q4	$13.5M	Sell	1,194,600 -75,736	-6%	-$1.19M	0.07%	345
2018 Q3	$23.8M	Buy	+1,270,336	New	+$29.2M	0.1%	260

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Steven Cohen's FLXN Position: Q3 2019 in Review

Steven Cohen sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2019, closing a stake of 80,700 shares — an estimated $993K sold.

Steven Cohen first reported a position in FLXN in Q3 2018 and held it in 3 quarters. The position peaked at $23.8M in Q3 2018. 126 funds tracked by Wall St. Rank hold FLXN as of Q3 2019.

Steven Cohen reported no remaining Flexion Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Steven Cohen sold 80,700 Flexion Therapeutics, Inc. shares in Q3 2019, an estimated $993K.
Steven Cohen first reported a position in Flexion Therapeutics, Inc. in Q3 2018 and held it in 3 quarters.
Steven Cohen's Flexion Therapeutics, Inc. position peaked at $23.8M in Q3 2018.
126 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.